September 4-5, 2003
Meeting Agenda

Wyndham Washington Hotel
1400 M Street, NW
Washington, DC 20005
202-429-1700

9:00 am	Session 1: The Meaning of Federal Funding. Peter Berkowitz, Associate Professor of Law, George Mason University Law School; Research Fellow, the Hoover Institution; and Senior Consultant, the President’s Council on Bioethics.
10:30 am	Break
10:45 am	Session 2: Stem Cells: The Administration’s Funding Policy: Legal and Moral Foundations Discussion of Staff Working Paper, “The Administration’s Stem Cell Research Funding Policy: Legal and Moral Foundations.”
12:15 pm	Lunch
2:00 pm	Session 3: Stem Cells: Moving Research from the Bench toward the Bedside: The Role of NIH and FDA Part I (60 min.): Elias A. Zerhouni, M.D., Director, National Institutes of Health. Part II (30 min.): Mark B. McClellan, M.D., Commissioner, Food & Drug Administration.
3:30 pm	Break
3:45 pm	Session 4: Stem Cells: Moving Research from the Bench toward the Bedside: The Role of Nongovernmental Activity. Thomas Okarma, President and CEO, Geron Corporation. Theo Palmer, Michael J. Fox Foundation for Parkinson’s Research. William Pursley, President and CEO, Osiris Therapeutics, Inc. Robert Goldstein, Juvenile Diabetes Research Foundation International.
5:15 pm	Adjournment

8:30 am	Session 5: Biotechnology & Public Policy: Proposed Interim Recommendations, I. Discussion of Parts I and II of Staff Working Paper, “U.S. Public Policy and the Biotechnologies that Touch the Beginnings of Human Life: Draft Recommendations.”
10:00 am	Break
10:15 am	Session 6: Biotechnology & Public Policy: Proposed Interim Recommendations, II. Discussion of Part III of Staff Working Paper, “U.S. Public Policy and the Biotechnologies that Touch the Beginnings of Human Life: Draft Recommendations."
11:30 am	Session 7: Public Comments
12:30 pm	Adjournment